Total Payments
$11,299
2024 Payments
$1,089
Companies
48
Transactions
756
Medicare Patients
21,825
Medicare Billing
$3.4M
Payment Breakdown by Category
Food & Beverage$11,280 (99.8%)
Education$19.24 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,280 | 752 | 99.8% |
| Education | $19.24 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,666 | 196 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,389 | 86 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $985.25 | 93 | $0 (2022) |
| ABBVIE INC. | $663.48 | 37 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $650.71 | 43 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $548.39 | 36 | $0 (2024) |
| Novo Nordisk Inc | $498.31 | 49 | $0 (2024) |
| Radius Health, Inc. | $428.76 | 21 | $0 (2024) |
| PFIZER INC. | $357.02 | 26 | $0 (2024) |
| Merck Sharp & Dohme LLC | $355.05 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,089 | 69 | Amgen Inc. ($335.21) |
| 2023 | $1,635 | 90 | Amgen Inc. ($383.12) |
| 2022 | $1,684 | 111 | Amgen Inc. ($262.61) |
| 2021 | $1,345 | 94 | Amgen Inc. ($345.16) |
| 2020 | $437.44 | 29 | Amgen Inc. ($156.20) |
| 2019 | $1,669 | 112 | Janssen Pharmaceuticals, Inc ($273.87) |
| 2018 | $1,953 | 139 | Amgen Inc. ($506.11) |
| 2017 | $1,487 | 112 | Amgen Inc. ($406.30) |
All Payment Transactions
756 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Inflammation | ||||||
| 12/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: PAIN | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $30.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Inflammation | ||||||
| 07/31/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: PSYCHIATRY | ||||||
| 06/25/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: VACCINES | ||||||
| 06/24/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $32.51 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 62 | 5,668 | 15,405 | $2.2M | $902,632 |
| 2022 | 69 | 5,659 | 17,818 | $2.3M | $943,416 |
| 2021 | 76 | 5,395 | 15,458 | $2.2M | $919,434 |
| 2020 | 69 | 5,103 | 15,667 | $1.9M | $676,283 |
Total Patients
21,825
Total Services
64,348
Medicare Billing
$3.4M
Procedure Codes
276
All Medicare Procedures & Services
276 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 933 | 4,738 | $1.1M | $443,155 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 759 | 2,066 | $318,164 | $135,797 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 404 | 404 | $99,788 | $53,651 | 53.8% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 32 | 32 | $128,000 | $39,070 | 30.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 133 | 205 | $62,320 | $28,567 | 45.8% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 32 | 64 | $64,000 | $26,114 | 40.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 178 | 246 | $49,200 | $22,732 | 46.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 201 | 315 | $47,250 | $21,167 | 44.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 110 | 114 | $51,528 | $17,682 | 34.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 138 | 139 | $11,120 | $10,538 | 94.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 59 | 67 | $28,743 | $10,254 | 35.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 57 | 57 | $20,634 | $9,646 | 46.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 339 | 339 | $13,540 | $6,517 | 48.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 134 | 158 | $15,800 | $6,326 | 40.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 32 | 128 | $19,200 | $5,364 | 27.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 147 | 148 | $8,880 | $4,684 | 52.7% |
| 75571 | Ct scan of heart with evaluation of blood vessel calcium | Office | 2023 | 56 | 57 | $12,711 | $4,554 | 35.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 340 | 387 | $13,932 | $4,067 | 29.2% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 21 | 21 | $11,970 | $3,938 | 32.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 25 | 25 | $11,100 | $3,890 | 35.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 203 | 203 | $7,917 | $3,875 | 48.9% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 34 | 35 | $12,250 | $3,848 | 31.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 21 | 21 | $7,371 | $3,561 | 48.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 136 | 308 | $13,552 | $3,417 | 25.2% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 24 | 28 | $7,364 | $2,840 | 38.6% |
About Dr. William Baker, M.D
Dr. William Baker, M.D is a Internal Medicine healthcare provider based in Bakersfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720040793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Baker, M.D has received a total of $11,299 in payments from pharmaceutical and medical device companies, with $1,089 received in 2024. These payments were reported across 756 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($11,280).
As a Medicare-enrolled provider, Baker has provided services to 21,825 Medicare beneficiaries, totaling 64,348 services with total Medicare billing of $3.4M. Data is available for 4 years (2020–2023), covering 276 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bakersfield, CA
- Active Since 04/05/2006
- Last Updated 06/11/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720040793
Products in Payments
- XARELTO (Drug) $790.83
- Repatha (Biological) $683.90
- TRELEGY ELLIPTA (Drug) $678.99
- Otezla (Drug) $666.40
- Aimovig (Biological) $453.08
- EVENITY (Biological) $377.63
- ENTRESTO (Drug) $353.51
- QULIPTA (Drug) $314.90
- BELSOMRA (Drug) $265.51
- Tymlos (Biological) $261.24
- Prolia (Biological) $258.66
- NUCALA (Biological) $239.53
- UBRELVY (Drug) $233.80
- BREZTRI (Drug) $221.52
- ANORO (Drug) $201.37
- INJECTAFER (Drug) $190.94
- INVOKANA (Drug) $187.56
- KRYSTEXXA (Biological) $185.10
- LEQVIO (Drug) $180.46
- Victoza (Drug) $178.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bakersfield
Franco Felizarta, Md, MD
Internal Medicine — Payments: $1.3M
Internal Medicine $1.3M
Dr. Soham Shah, M.d, M.D
Internal Medicine — Payments: $843,865
Internal Medicine $843,865
Dr. Hashim Kazmi, Md, MD
Internal Medicine — Payments: $122,044
Internal Medicine $122,044
Dr. Jeffrey Bacon, D.o, D.O
Internal Medicine — Payments: $108,805
Internal Medicine $108,805
Gurjit Singh, M.d, M.D
Internal Medicine — Payments: $54,630
Internal Medicine $54,630
Dr. Carlos Alvarez, Md, MD
Internal Medicine — Payments: $26,676
Internal Medicine $26,676